2026-526171-32-00RecruitingPhase 1
A trial to learn how safe anifrolumab is, how it moves throughout the body over time, and how it affects the body of adults with systemic lupus erythematosus
Source: EU CTIS (euclinicaltrials.eu) · Last updated 25 Sept 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 13 (estimated)
- First submitted
- 3 Jun 2026
- Start date
- 23 Oct 2026
- Lead sponsor
- AstraZeneca AB
- Diseases
- Lupus (SLE)
- EU CT number
- 2026-526171-32-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 13
- 7 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with systemic lupus erythematosus. It studies how safe anifrolumab is and how it moves through the body.
- Age
- 18 years or older
- Sex
- All sexes can join.
Read by machine on 9 Nov 2026.
Sites (7)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Article 11 CTR HU | DO NOT EDIT | Hungary | Completed |
| Szpital Uniwersytecki nr 2 im dr Jana Biziela w Bydgoszczy | Bydgoszcz | Poland | Recruiting |
| Promed P.Lach R.Glowacki Sp. j. | Cracow | Poland | Recruiting |
| Provita Sp z o o | Katowice | Poland | Recruiting |
| Ai Centrum Medyczne Sp. Z O.O. | Poznan | Poland | Recruiting |
| Medicover Integrated Clinical Services Sp. z o.o. | Warsaw | Poland | Recruiting |
| Klinika Reuma Park Sp. z o.o. S.K. | Warsaw | Poland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.